Spinal Muscular Atrophy Medicine Market - Global Outlook and Forecast 2021-2027

Code: RW00014560615
Market Monitor Global
Oct-2021
Life Sciences
100 Pages

This report contains market size and forecasts of Spinal Muscular Atrophy Medicine in global, including the following market information:
Global Spinal Muscular Atrophy Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Spinal Muscular Atrophy Medicine Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Spinal Muscular Atrophy Medicine companies in 2020 (%)
The global Spinal Muscular Atrophy Medicine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Spinal Muscular Atrophy Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spinal Muscular Atrophy Medicine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Spinal Muscular Atrophy Medicine Market Segment Percentages, By Type, 2020 (%)
LMI-070
ND-602
NT-1654
Nusinersen
NXD-30001
Others

Global Spinal Muscular Atrophy Medicine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Spinal Muscular Atrophy Medicine Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Spinal Muscular Atrophy Medicine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Spinal Muscular Atrophy Medicine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spinal Muscular Atrophy Medicine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Spinal Muscular Atrophy Medicine revenues share in global market, 2020 (%)
Key companies Spinal Muscular Atrophy Medicine sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Spinal Muscular Atrophy Medicine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma Inc.
AveXis, Inc.
Bioblast Pharma Ltd.
Cytokinetics, Inc. 24
F. Hoffmann-La Roche Ltd.
Genethon
Genzyme Corporation
GMP-Orphan SAS
Ionis Pharmaceuticals, Inc.
Longevity Biotech, Inc
Neurodyn Inc.
Neurotune AG
Novartis AG
Sarepta Therapeutics, Inc.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Spinal Muscular Atrophy Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Spinal Muscular Atrophy Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Spinal Muscular Atrophy Medicine Overall Market Size
2.1 Global Spinal Muscular Atrophy Medicine Market Size: 2021 VS 2027
2.2 Global Spinal Muscular Atrophy Medicine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Spinal Muscular Atrophy Medicine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Spinal Muscular Atrophy Medicine Players in Global Market
3.2 Top Global Spinal Muscular Atrophy Medicine Companies Ranked by Revenue
3.3 Global Spinal Muscular Atrophy Medicine Revenue by Companies
3.4 Global Spinal Muscular Atrophy Medicine Sales by Companies
3.5 Global Spinal Muscular Atrophy Medicine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Spinal Muscular Atrophy Medicine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Spinal Muscular Atrophy Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Spinal Muscular Atrophy Medicine Players in Global Market
3.8.1 List of Global Tier 1 Spinal Muscular Atrophy Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Spinal Muscular Atrophy Medicine Market Size Markets, 2021 & 2027
4.1.2 LMI-070
4.1.3 ND-602
4.1.4 NT-1654
4.1.5 Nusinersen
4.1.6 NXD-30001
4.1.7 Others
4.2 By Type - Global Spinal Muscular Atrophy Medicine Revenue & Forecasts
4.2.1 By Type - Global Spinal Muscular Atrophy Medicine Revenue, 2016-2021
4.2.2 By Type - Global Spinal Muscular Atrophy Medicine Revenue, 2022-2027
4.2.3 By Type - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2016-2027
4.3 By Type - Global Spinal Muscular Atrophy Medicine Sales & Forecasts
4.3.1 By Type - Global Spinal Muscular Atrophy Medicine Sales, 2016-2021
4.3.2 By Type - Global Spinal Muscular Atrophy Medicine Sales, 2022-2027
4.3.3 By Type - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2016-2027
4.4 By Type - Global Spinal Muscular Atrophy Medicine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Spinal Muscular Atrophy Medicine Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Spinal Muscular Atrophy Medicine Revenue & Forecasts
5.2.1 By Application - Global Spinal Muscular Atrophy Medicine Revenue, 2016-2021
5.2.2 By Application - Global Spinal Muscular Atrophy Medicine Revenue, 2022-2027
5.2.3 By Application - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2016-2027
5.3 By Application - Global Spinal Muscular Atrophy Medicine Sales & Forecasts
5.3.1 By Application - Global Spinal Muscular Atrophy Medicine Sales, 2016-2021
5.3.2 By Application - Global Spinal Muscular Atrophy Medicine Sales, 2022-2027
5.3.3 By Application - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2016-2027
5.4 By Application - Global Spinal Muscular Atrophy Medicine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Spinal Muscular Atrophy Medicine Market Size, 2021 & 2027
6.2 By Region - Global Spinal Muscular Atrophy Medicine Revenue & Forecasts
6.2.1 By Region - Global Spinal Muscular Atrophy Medicine Revenue, 2016-2021
6.2.2 By Region - Global Spinal Muscular Atrophy Medicine Revenue, 2022-2027
6.2.3 By Region - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2016-2027
6.3 By Region - Global Spinal Muscular Atrophy Medicine Sales & Forecasts
6.3.1 By Region - Global Spinal Muscular Atrophy Medicine Sales, 2016-2021
6.3.2 By Region - Global Spinal Muscular Atrophy Medicine Sales, 2022-2027
6.3.3 By Region - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Spinal Muscular Atrophy Medicine Revenue, 2016-2027
6.4.2 By Country - North America Spinal Muscular Atrophy Medicine Sales, 2016-2027
6.4.3 US Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.4.4 Canada Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.4.5 Mexico Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Spinal Muscular Atrophy Medicine Revenue, 2016-2027
6.5.2 By Country - Europe Spinal Muscular Atrophy Medicine Sales, 2016-2027
6.5.3 Germany Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.5.4 France Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.5.5 U.K. Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.5.6 Italy Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.5.7 Russia Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.5.8 Nordic Countries Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.5.9 Benelux Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Spinal Muscular Atrophy Medicine Revenue, 2016-2027
6.6.2 By Region - Asia Spinal Muscular Atrophy Medicine Sales, 2016-2027
6.6.3 China Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.6.4 Japan Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.6.5 South Korea Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.6.6 Southeast Asia Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.6.7 India Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Spinal Muscular Atrophy Medicine Revenue, 2016-2027
6.7.2 By Country - South America Spinal Muscular Atrophy Medicine Sales, 2016-2027
6.7.3 Brazil Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.7.4 Argentina Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Sales, 2016-2027
6.8.3 Turkey Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.8.4 Israel Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.8.5 Saudi Arabia Spinal Muscular Atrophy Medicine Market Size, 2016-2027
6.8.6 UAE Spinal Muscular Atrophy Medicine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Corporate Summary
7.1.2 Astellas Pharma Inc. Business Overview
7.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.1.4 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.1.5 Astellas Pharma Inc. Key News
7.2 AveXis, Inc.
7.2.1 AveXis, Inc. Corporate Summary
7.2.2 AveXis, Inc. Business Overview
7.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.2.4 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.2.5 AveXis, Inc. Key News
7.3 Bioblast Pharma Ltd.
7.3.1 Bioblast Pharma Ltd. Corporate Summary
7.3.2 Bioblast Pharma Ltd. Business Overview
7.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Major Product Offerings
7.3.4 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.3.5 Bioblast Pharma Ltd. Key News
7.4 Cytokinetics, Inc. 24
7.4.1 Cytokinetics, Inc. 24 Corporate Summary
7.4.2 Cytokinetics, Inc. 24 Business Overview
7.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Major Product Offerings
7.4.4 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.4.5 Cytokinetics, Inc. 24 Key News
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 Genethon
7.6.1 Genethon Corporate Summary
7.6.2 Genethon Business Overview
7.6.3 Genethon Spinal Muscular Atrophy Medicine Major Product Offerings
7.6.4 Genethon Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.6.5 Genethon Key News
7.7 Genzyme Corporation
7.7.1 Genzyme Corporation Corporate Summary
7.7.2 Genzyme Corporation Business Overview
7.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Major Product Offerings
7.4.4 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.7.5 Genzyme Corporation Key News
7.8 GMP-Orphan SAS
7.8.1 GMP-Orphan SAS Corporate Summary
7.8.2 GMP-Orphan SAS Business Overview
7.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Major Product Offerings
7.8.4 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.8.5 GMP-Orphan SAS Key News
7.9 Ionis Pharmaceuticals, Inc.
7.9.1 Ionis Pharmaceuticals, Inc. Corporate Summary
7.9.2 Ionis Pharmaceuticals, Inc. Business Overview
7.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.9.4 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.9.5 Ionis Pharmaceuticals, Inc. Key News
7.10 Longevity Biotech, Inc
7.10.1 Longevity Biotech, Inc Corporate Summary
7.10.2 Longevity Biotech, Inc Business Overview
7.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Major Product Offerings
7.10.4 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.10.5 Longevity Biotech, Inc Key News
7.11 Neurodyn Inc.
7.11.1 Neurodyn Inc. Corporate Summary
7.11.2 Neurodyn Inc. Spinal Muscular Atrophy Medicine Business Overview
7.11.3 Neurodyn Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.11.4 Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.11.5 Neurodyn Inc. Key News
7.12 Neurotune AG
7.12.1 Neurotune AG Corporate Summary
7.12.2 Neurotune AG Spinal Muscular Atrophy Medicine Business Overview
7.12.3 Neurotune AG Spinal Muscular Atrophy Medicine Major Product Offerings
7.12.4 Neurotune AG Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.12.5 Neurotune AG Key News
7.13 Novartis AG
7.13.1 Novartis AG Corporate Summary
7.13.2 Novartis AG Spinal Muscular Atrophy Medicine Business Overview
7.13.3 Novartis AG Spinal Muscular Atrophy Medicine Major Product Offerings
7.13.4 Novartis AG Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.13.5 Novartis AG Key News
7.14 Sarepta Therapeutics, Inc.
7.14.1 Sarepta Therapeutics, Inc. Corporate Summary
7.14.2 Sarepta Therapeutics, Inc. Business Overview
7.14.3 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.14.4 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.14.5 Sarepta Therapeutics, Inc. Key News
7.15 Voyager Therapeutics, Inc.
7.15.1 Voyager Therapeutics, Inc. Corporate Summary
7.15.2 Voyager Therapeutics, Inc. Business Overview
7.15.3 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.15.4 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.15.5 Voyager Therapeutics, Inc. Key News
7.16 Vybion, Inc.
7.16.1 Vybion, Inc. Corporate Summary
7.16.2 Vybion, Inc. Business Overview
7.16.3 Vybion, Inc. Spinal Muscular Atrophy Medicine Major Product Offerings
7.16.4 Vybion, Inc. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.16.5 Vybion, Inc. Key News
7.17 WAVE Life Sciences Ltd.
7.17.1 WAVE Life Sciences Ltd. Corporate Summary
7.17.2 WAVE Life Sciences Ltd. Business Overview
7.17.3 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Major Product Offerings
7.17.4 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales and Revenue in Global (2016-2021)
7.17.5 WAVE Life Sciences Ltd. Key News
8 Global Spinal Muscular Atrophy Medicine Production Capacity, Analysis
8.1 Global Spinal Muscular Atrophy Medicine Production Capacity, 2016-2027
8.2 Spinal Muscular Atrophy Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Spinal Muscular Atrophy Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Spinal Muscular Atrophy Medicine Supply Chain Analysis
10.1 Spinal Muscular Atrophy Medicine Industry Value Chain
10.2 Spinal Muscular Atrophy Medicine Upstream Market
10.3 Spinal Muscular Atrophy Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Spinal Muscular Atrophy Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Spinal Muscular Atrophy Medicine in Global Market
Table 2. Top Spinal Muscular Atrophy Medicine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Spinal Muscular Atrophy Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Spinal Muscular Atrophy Medicine Revenue Share by Companies, 2016-2021
Table 5. Global Spinal Muscular Atrophy Medicine Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Spinal Muscular Atrophy Medicine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Spinal Muscular Atrophy Medicine Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Spinal Muscular Atrophy Medicine Product Type
Table 9. List of Global Tier 1 Spinal Muscular Atrophy Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Astellas Pharma Inc.
AveXis, Inc.
Bioblast Pharma Ltd.
Cytokinetics, Inc. 24
F. Hoffmann-La Roche Ltd.
Genethon
Genzyme Corporation
GMP-Orphan SAS
Ionis Pharmaceuticals, Inc.
Longevity Biotech, Inc
Neurodyn Inc.
Neurotune AG
Novartis AG
Sarepta Therapeutics, Inc.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE